Vaginale Kontrazeption |
| |
Authors: | Prof. Dr. H.-J. Ahrendt C. Friedrich D. Foth |
| |
Affiliation: | 1. Praxis für Frauenheilkunde, Klinische Forschung und Weiterbildung, Halberst?dter Str. 122, 39112, Magdeburg, Deutschland 2. Praxis für Gyn?kologie und Geburtshilfe, Sexualmedizin, K?then (Anhalt), Deutschland 3. MVZ PAN Institut für Endokrinologie und Reproduktionsmedizin, K?ln, Deutschland
|
| |
Abstract: |
Dosage and indications The vaginal rings NuvaRing® and Circlet® are combination hormonal preparations which emit 15 µg ethinyl estradiol and 120 µg etonogestrel daily. The dosages are therefore very low. These vaginal rings are combination products which are applicable for any woman of any age and are not niche products for special indications. Handling and safety The handling and insertion of the ring into the vagina and removal are simple. A negative impact on sexual behavior and experience are not to be expected. Because of the very low continuously delivered dose of ethinyl estradiol, substantially less additional bleeding occurs than with oral combination products. Other advantages of the vaginal ring are very good Pearl index and the high acceptability and compliance. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|